ANAVEX LIFE SCIENCES CORP. (NASDAQ:AVXL) Files An 8-K Other Events
Item 8.01 Other Events.
On March 18, 2019, Anavex Life Sciences Corp. (the Company) filed a prospectus supplement (the Prospectus Supplement) to its effective registration statement on Form S-3 (File No.333-207600) registering shares of the Companys common stock, $0.001 par value per share, issuable to its purchase agreement with Lincoln Park Capital Fund, LLC. This Current Report on Form 8-K is being filed solely to include the opinion of counsel attached hereto as Exhibit 5.1 with respect to the legality of the shares issuable to the Prospectus Supplement.
(d) Exhibits
| 5.1 | Opinion of Snell Wilmer, L.L.P. |
| 23.1 | Consent of Snell Wilmer, L.L.P. (contained in Exhibit 5.1) |
ANAVEX LIFE SCIENCES CORP. Exhibit
EX-5.1 2 s116758_ex5-1.htm EXHIBIT 5.1 Exhibit 5.1 March 18,…
To view the full exhibit click here
